Shire PLC (LON:SHP)‘s stock had its “overweight” rating reaffirmed by JPMorgan Chase & Co. in a research note issued to investors on Friday.
Other research analysts have also issued research reports about the stock. Deutsche Bank AG reaffirmed a “buy” rating and issued a GBX 5,600 ($73.10) price target on shares of Shire PLC in a research note on Monday, June 13th. Royal Bank Of Canada reaffirmed an “outperform” rating on shares of Shire PLC in a research note on Friday, July 22nd. Jefferies Group lifted their price target on shares of Shire PLC from GBX 6,050 ($78.97) to GBX 6,600 ($86.15) and gave the company a “buy” rating in a research note on Wednesday, August 3rd. Citigroup Inc. reiterated a “buy” rating on shares of Shire PLC in a report on Wednesday, August 3rd. Finally, Credit Suisse Group AG lifted their price objective on shares of Shire PLC from GBX 5,000 ($65.27) to GBX 5,200 ($67.88) and gave the company an “outperform” rating in a report on Wednesday, August 3rd. One research analyst has rated the stock with a sell rating, two have given a hold rating, sixteen have assigned a buy rating and one has assigned a strong buy rating to the company. The stock has a consensus rating of “Buy” and an average price target of GBX 5,831.33 ($76.12).
Shares of Shire PLC (LON:SHP) opened at 5124.00 on Friday. The firm has a 50-day moving average of GBX 4,983.69 and a 200-day moving average of GBX 4,482.86. The company’s market capitalization is GBX 34.99 billion. Shire PLC has a one year low of GBX 2,707.19 and a one year high of GBX 5,377.00.
The firm also recently announced a dividend, which will be paid on Friday, October 7th. Stockholders of record on Thursday, September 8th will be given a GBX 3.51 ($0.05) dividend. The ex-dividend date is Thursday, September 8th. This represents a dividend yield of 0.07%.
In other Shire PLC news, insider Bohuon,Olivier bought 134 shares of Shire PLC stock in a transaction dated Thursday, June 30th. The stock was bought at an average price of GBX 4,463 ($58.26) per share, with a total value of £5,980.42 ($7,806.32).
About Shire PLC
Shire plc is a biotech company. The Company, along with its subsidiaries, is engaged in developing and marketing medicines for patients with rare diseases and other select conditions. The Company operates in the segment of research, development, licensing, manufacturing, marketing, distribution and sale of specialist medicines.
Receive News & Ratings for Shire PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shire PLC and related companies with MarketBeat.com's FREE daily email newsletter.